Your browser doesn't support javascript.
loading
Low platelet count reduces subsequent complete remission rate despite marrow with <5% blasts after AML induction therapy.
Chen, X; Newell, L F; Xie, H; Walter, R B; Pagel, J M; Sandhu, V K; Becker, P S; Hendrie, P C; Abkowitz, J L; Appelbaum, F R; Estey, E H.
Affiliation
  • Chen X; Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.
  • Newell LF; Division of Hematology and Medical Oncology, Department of Medicine, Oregon Health & Science University (OHSU) Knight Cancer Institute, Portland, OR, USA.
  • Xie H; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Walter RB; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA [3] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Pagel JM; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Sandhu VK; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Becker PS; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA [3] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Hendrie PC; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Abkowitz JL; Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Appelbaum FR; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
  • Estey EH; 1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Division of Hematology, Department of Medicine, University of Washington, Seattle, WA, USA [3] Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA, USA.
Leukemia ; 29(8): 1779-80, 2015 Aug.
Article in En | MEDLINE | ID: mdl-25650090
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Cells / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Blast Crisis Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Leukemia Year: 2015 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bone Marrow Cells / Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols / Blast Crisis Type of study: Prognostic_studies Limits: Female / Humans / Male / Middle aged Language: En Journal: Leukemia Year: 2015 Document type: Article